Two general routes to 1,4-disubstituted-2,3,4,5-tetrahydro-1H-3-benzazepines

Organic Letters

Volumn 2, Issue 25, 2000, Pages 4099-4102

  Gerritz, Samuel W ^a   Smith, Jennifer S ^a   Nanthakumar, Suganthini S ^a,b   Uehling, David E ^a   Cobb, Jeffery E ^a  

^a GLAXOSMITHKLINE   (United States)

^b VERTEX PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZAZEPINE DERIVATIVE; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; GUANINE NUCLEOTIDE BINDING PROTEIN;

ARTICLE; CYCLIZATION; DRUG ANTAGONISM; METABOLISM; SYNTHESIS;

BENZAZEPINES; CYCLIZATION; DOPAMINE ANTAGONISTS; GTP-BINDING PROTEINS; INDICATORS AND REAGENTS; RECEPTORS, DOPAMINE D1;

EID: 0034649723     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol0067641     Document Type: Article

References (21)

1. For the remainder of this Letter, we will refer to 2,3,4,5-tetrahydro-1H-3-benzazepines as 3-benzazepines.
2. Reviews: (a) Weinstock, J.; Hieble, J. P.; Wilson, J. W., III. Drugs Future 1985, 10, 645.
3. (b) Barnett, A.; Gold, E. H.; Chipkin, R. E.; Iorio, L. C. Adv. Biosci. 1990, 77. 1.
4. (c) Iorio, L. C.; Barnett, A.; Billard, W.; Gold, E. H. Adv. Exp. Med. Biol. 1986, 204, 1.
5. (a) Walter, L. A.; Chang, W. K. U.S. Patent 3393192, 1968: Chem. Abstr. 1969, 96507.
6. (b) Kasparek, S. Adv. Heterocycl. Chem. 1974, 17, 45.
7. (c) Berger, J. G.; Chang, W. K.; Clader, J. W.; Hou, D.; Chipkin, R. E.; McPhail, A. T. J. Med. Chem. 1989, 32, 1913.
8. (c) Chumpradit, S.; Kung, M. P., Billings, J. J.; Kung, H. F. J. Med. Chem. 1991, 34, 877.
9. The synthesis of a 1-phenyl-4-methyl-3-benzazepine is described in ref 3a, but no additional 4-position substituents were reported. (5) This synthetic step is reported in ref 3a without yield information.
10. All new compounds reported herein provided analytical data consistent with their proposed structures.
11. Nahm, S.; Weinreb, S. M. Tetrahedron Lett. 1981, 22, 3815.
12. Borch, R. F.; Bernstein, M. D.; Durst, H. D. J. Am. Chem. Soc. 1971, 93, 2897.
13. (a) Senkus, M. J. Am. Chem. Soc. 1945, 67, 1515.
14. (b) Goodson, L. H.; Christopher, H. J. Am. Chem. Soc. 1950, 72, 358.
15. (c) Neelakantan, L. J. Org. Chem. 1971, 36, 2256.
16. (d) Takahashi, H.; Niwa, H.; Higashiyama, K. Heterocycles 1988, 27, 2099.
17. (e) Davidsen, S. K.; Chu-Moyer, M. Y. J. Org. Chem. 1989, 54, 5558.
18. i = H) via borohydride reduction: (a) Labaw, C. S.; Tremper, A. W. Eur. Pat. Appl. 177326, 1985; Chem. Abstr. 1985, 60593.
19. (b) Coote, S. J.; Davies, S. G.; Middlemiss, D.; Naylor, A. Tetrahedron Lett. 1989, 30, 3581.
20. Our asymmetric synthesis of 1,4-disubstituted-3-benzazepines will be disclosed in a subsequent publication.
21. Sill, A. D.; Housmyer, C. L.; Gibboney, K. Tetrahedron 1987, 43, 1177.